Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Nobel is 0.1% (very low). The 2024 annual accounts show equity of €5.40M and a net result of €170k. Equity is growing by ~16.7% per year across the filed fiscal years. Its solvency ranks better than 67% of 1697 sector peers (fiscal year 2024). The company has been active since 1973 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 6 annual accounts.
Signals
1 signal · with evidenceSignals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Trust signals
2 signalsAdministrative Flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
Annual accounts & ratios
Source: NBB · 2024How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 32.2% | 14.3% | |
| Net result | €170k | €0 | |
| Equity | €5.40M | €108k | |
| Gross operating margin | €1.52M | €52k | |
| Employees (FTE) | 0.0 | 0.0 |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €1.40M |
| Net profit | €170k |
| Cash flow | €856k |
| Staff costs | - |
| Income taxes | €73k |
| Dividends | - |
| Total assets | €16.79M |
| Equity | €5.40M |
| Debt | €10.68M |
| of which ≤ 1y | €2.08M |
| of which > 1y | €8.56M |
| Working capital | €93k |
| Employees (FTE) | 0.0 |
| 2024 | |
|---|---|
| Current ratio | 1.04 |
| Quick ratio | 0.62 |
| Working capital ratio | 0.6% |
| Solvency | 32.2% |
| Debt / equity | 1.98 |
| Long-term debt ratio | 1.58 |
| Interest coverage | 2.50 |
| Gross margin | - |
| Net margin | - |
| ROA | 1.0% |
| ROE | 3.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €16.79M |
| Fixed assets | 21/28 | €14.61M |
| Intangible fixed assets | 21 | €85k |
| Tangible fixed assets | 22/27 | €14.38M |
| Financial fixed assets | 28 | €150k |
| Current assets | 29/58 | €2.18M |
| Stocks & contracts in progress | 3 | €890k |
| Amounts receivable within one year | 40/41 | €1.21M |
| Cash & bank | 54/58 | €26k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €16.79M |
| Equity | 10/15 | €5.40M |
| Contributions / capital | 10/11 | €5.15M |
| Reserves | 13 | €317k |
| Accumulated profits (losses) | 14 | €-61k |
| Provisions & deferred taxes | 16 | €706k |
| Amounts payable | 17/49 | €10.68M |
| Amounts payable after one year | 17 | €8.56M |
| Amounts payable within one year | 42/48 | €2.08M |
| Trade debts payable within one year | 44 | €48k |
| Income statement | ||
| Gross operating margin | 9900 | €1.52M |
| Operating result | 9901 | €711k |
| Financial income | 75 | €32k |
| Financial charges | 65 | €559k |
| Result before taxes | 9903 | €184k |
| Income taxes | 67/77 | €73k |
| Net result for the period | 9904 | €170k |
| Result to be appropriated | 9905 | €169k |
Health barometer
FY 2024 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Directors
Directors & mandates
12 directorsHistoric, not recently confirmed (11)
-
Not recently confirmedlast confirmed in an act from 2019
2 events
- 24-09-2019 Appointed· Director
- 04-09-2019 Appointed· Managing director
-
HUMACONLegal entityDirector· perm. rep.: Sébastien HendrickxState Gazette act 19126913 (24-09-2019)Not recently confirmedlast confirmed in an act from 2019
2 events
- 24-09-2019 Appointed· Director
- 04-09-2019 Appointed· Managing director
-
AMAURY DE CROMBRUGGHELegal entityDirector· perm. rep.: Amaury de CrombruggheState Gazette act 19068881 (22-05-2019)Not recently confirmedlast confirmed in an act from 2019
2 events
- 22-05-2019 Mandate renewed· Director
- 21-06-2017 Appointed· Director
-
MARC VAN BEGINLegal entityDirector· perm. rep.: Marc Van BeginState Gazette act 19068881 (22-05-2019)Not recently confirmedlast confirmed in an act from 2019
-
Not recently confirmedlast confirmed in an act from 2019
2 events
- 22-05-2019 Mandate renewed· Director
- 24-05-2017 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2017
3 events
- 24-05-2017 Appointed· Director
- 12-05-2017 Resigned· Director
- 31-10-2016 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2016
-
BVBA Marc Var BeginLegal entityDirector· perm. rep.: Marc Van BeginState Gazette act 14111179 (04-06-2014)Not recently confirmedlast confirmed in an act from 2014
-
BVBA STRA-GOLegal entityDirector· perm. rep.: Charles van der Straten WailletState Gazette act 14111179 (04-06-2014)Not recently confirmedlast confirmed in an act from 2014
-
Not recently confirmedlast confirmed in an act from 2014
-
Not recently confirmedlast confirmed in an act from 2010
Former directors (1)
-
Former- → 14-04-2010
Statutory auditor
3 auditors| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Vyvey & C° Bedrijfsrevisoren BVCurrent Company auditor · represented by Steven Vyvey |
- | 30-07-2025 → present |
| KPMG Réviseurs d'Entreprises Statutory auditor · represented by Filip De Bock |
- | 18-08-2010 → 12-06-2018 |
| PricewaterhouseCoopers Reviseurs d'Entreprises Statutory auditor · represented by Didier Matriche |
- | 12-06-2018 → 01-09-2019 |
Insolvency mandates
Legal Structure
| NACE primary | Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen(68203) |
| Legal form | Public limited company(014) |
| Incorporation | 05-12-1973 |
| Status | Active |
| Postal code | 2000 |
Structure & network
Connections & network
55 connected companiesLocations & real estate
Establishment units
1 locationReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11811L3587/00B004 | Flanders | 546 m² | 1 · 284 m² | 19.4 m · 6 fl. |
Publications
Lifecycle & Insolvency Signals
Belgian State Gazette · acts
1 verified actWhat every Belgian State Gazette publication actually says, each act broken down into appointments, capital movements, seat moves and statute amendments.
- Merger
- Corporate purpose , De vennootschap heeft tot voorwerp om voor zichzelf of voor rekening van derden, alle industriële-, handels-, financiële en onroerende handelingen te stellen, d…
- Corporate purpose , De vennootschap heeft tot voorwerp, zowel in België als in het buitenland, voor eigen rekening of voor rekening van derden, of door deelname van dezen: Overige…
- Accounting effect , 1 januari 2026
- Net-asset statement , 909092.67, EUR
- Power of attorney, Marie-Ghislaine Brosens
Analysis
Snowflake analysis
financial profile on 5 axesStrong profile, led by stability.
All 5 axes are computed from data Checked has read.
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
AI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, ranked by comparable sizeCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameNL | Nobel |